icon-    folder.gif   Conference Reports for NATAP  
 
  26th Conference of the Asian Pacific
Association for the Study of the Liver
2017 APASL, Feb 15-19
Shanghai, China

Back grey_arrow_rt.gif
 
 
 
GARNET: High SVR Rates Following 8-Week Treatment With Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir in Patients With HCV Genotype 1b Infection
 
 
  Reported by Jules Levin
26th Conference of the Asian Pacifi c Associati on for the Study of the Liver (APASL), 1519 February 2017, Shanghai, China
 
Tania M Welzel1, Stefan Zeuzem1, Emily O Dumas2, Tarik Asselah3, David Shaw4, Rawi Hazzan5,
Xavier Forns6, Tami Pilot-Mati as3, Wenjing Lu3, Daniel E Cohen3, Jordan Feld7 1JW Goethe University, Frankfurt, Germany; 2AbbVie Inc., North Chicago, Illinois, United States; 3Centre de Recherche sur l'Inflammation, Inserm UMR 1149, Universite Paris Diderot, AP-HP Hopital Beaujon, Clichy, France; 4Royal Adelaide Hospital, Adelaide, South Australia, Australia; 5Ha'emek Medical Center, Afula, Israel; 6Liver Unit, Hospital Clinic, CIBEREHD, IDIBAPS, Barcelona, Spain; 7Toronto Centre for Liver Disease, University of Toronto, Toronto, Ontario, Canada

CROI1

CROI2

CROI3

CROI4

CROI5

CROI6

CROI7